This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Surescripts, Allscripts file replies in support of dismissing claims in e-prescription monopolization case

( January 29, 2021, 22:31 GMT | Official Statement) -- MLex Summary: Surescripts and Allscripts Healthcare Solutions filed reply briefs urging a US federal judge to dismiss claims that they conspired to maintain a monopoly over the markets for electronic prescription routing and ‘e-prescribing’ services. Allscripts said that it was a customer of Superscript’s and therefore had no reason to reach agreement. Surescripts said that plaintiffs were indirect purchasers lacking standing to bring antitrust claims.See documents below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections